Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.
Curve Biosciences has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Curve Biosciences's investors include NZVC, First Spark Ventures, Civilization Ventures, Life Extension Ventures, LifeX Ventures.
Curve Biosciences is headquartered in Mountain View, United States.
Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.
Curve Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curve Biosciences — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/curve-biosciences. Accessed October 29, 2026.
VCBacked. (2025). Curve Biosciences — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/curve-biosciences
{{cite web |title=Curve Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/curve-biosciences |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated